Smith Chas P & Associates PA Cpas Sells 100,283 Shares of Johnson & Johnson $JNJ

Firm reduces stake in pharmaceutical giant by 38.6% in third quarter

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Smith Chas P & Associates PA Cpas, a financial advisory firm, reduced its stake in Johnson & Johnson (NYSE:JNJ) by 38.6% during the third quarter, according to a recent 13F filing with the SEC. The firm sold 100,283 shares of the pharmaceutical company's stock, leaving it with 159,194 shares worth $29.5 million as of the end of the quarter.

Why it matters

Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a portfolio spanning pharmaceuticals, medical devices, and consumer products. The reduction in Smith Chas P & Associates' stake in the company could signal a shift in the firm's investment strategy or a reallocation of assets, which may be of interest to investors tracking institutional holdings and sentiment around the stock.

The details

According to the 13F filing, Smith Chas P & Associates PA Cpas sold 100,283 shares of Johnson & Johnson during the third quarter, reducing its total position by 38.6%. The firm now holds 159,194 shares of the company's stock, which represents 2.6% of its overall portfolio. Johnson & Johnson is the firm's 12th largest holding.

  • Smith Chas P & Associates PA Cpas reduced its stake in Johnson & Johnson during the third quarter of 2026.

The players

Smith Chas P & Associates PA Cpas

A financial advisory firm that manages investments and provides accounting services.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer products.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Smith Chas P & Associates' stake in Johnson & Johnson could be a sign of broader portfolio rebalancing or a shift in the firm's investment strategy, though the reasons behind the move are not explicitly stated. Investors may want to monitor institutional holdings and sentiment around the stock to gauge broader market sentiment.